Delivery Order SPE2DB20D2104-SPE2DB25FMZFC
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) valued at $7,699.78 with a firm fixed price contract type. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $1,529.88 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count packages) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The award was competitively procured with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $4,256.00 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count supply) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a $4,824.44 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,647.26 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-unit count). This firm fixed price, competitively awarded contract was executed on August 4, 2025, with an ultimate completion date of August 5, 2025. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $19,348.64 to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count) on September 15, 2025, with completion due by September 16, 2025. This firm fixed-price delivery order, which is not set-aside, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $32,615.97 to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract type. The award was issued on September 19, 2025, with an ultimate completion date of September 22, 2025, and no set-aside designation was utilized. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of MULTAQ 400 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $3,136.74. The contract, which is classified as a child award, is non-set-aside and competitively awarded, with an ultimate completion date of August 14, 2025. Place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract. The award, valued at $4,604.72, represents a non-set-aside competitive award with an ultimate completion date of June 10, 2025. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 MG tablets (60-count packages) valued at $2,931.72. This firm fixed-price contract was competitively awarded without set-aside designation and is scheduled for completion by July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMZFCDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,529.88 to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count units) on August 29, 2025, with completion scheduled for September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026. The underlying IDC represents a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. The prime contract encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard. The DLA Troop Support is planning successor Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, reflecting the strategic importance of pharmaceutical supply chain management for federal defense and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/29/25 |